Abstract Agonism of the glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) has been effective at treating aspects of addictive behavior for a number of abused substances, including cocaine
These products are not approved for, and may not be used in, diagnostic, therapeutic, or clinical procedures, or for administration to humans or animals under any circumstances
Through Tirzepatides unique dual-action system, it has become the leading option for weight loss medications, setting the standard and paving the way for newer treatments like Retatrutide
Many GLP1 medications were originally developed for type 2 diabetes, and weight loss is a common beneficial effect
It plays a structural role in collagen, calcium absorption, and immune function and has a well-studied antiviral role in suppressing herpes simplex (HSV-1) outbreaks by blocking the arginine pathway the virus needs to replicate